Interaction of white and pink grapefruit juice with acetaminophen (paracetamol) in vivo in mice

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 795-798

  Dasgupta, Amitava ^a   Reyes, Meredith A ^a   Risin, Semyon A ^a   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Acetaminophen; Bioavailability; Fluorescence polarization immunoassay; Grapefruit juice; Half life

Indexed keywords

CYTOCHROME P450 3A4; DRUG METABOLIZING ENZYME; GLYCOPROTEIN P; LIVER ENZYME; PARACETAMOL;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; BLOOD ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; FEEDING; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HALF LIFE TIME; IN VIVO STUDY; MOUSE; NONHUMAN; PINK GRAPEFRUIT JUICE; PRIORITY JOURNAL; WHITE GRAPEFRUIT JUICE;

ACETAMINOPHEN; ANIMALS; BEVERAGES; CITRUS PARADISI; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOOD-DRUG INTERACTIONS; HALF-LIFE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PLANT PREPARATIONS;

CITRUS X PARADISI; MUS;

EID: 57349143594     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0059     Document Type: Article

References (24)

1. Bailey DG, Spence JD, Munoz C, Arnold JM: Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-269.
2. Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R: Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies. Drug Saf 2005;28:677-694.
3. Dahan A, Altman H: Food-drug interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance. Eur J Clin Nutr 2004;58:1-9.
4. Tian R, Koyabu N, Takanaga H, Matsuo H, Ohtani H, Sawada Y: Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 2002;19:802-809.
5. Girennavar B, Poulose SM, Jayaprakasha GK, Bhat NG, Patil BS: Furocoumarin from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes. Bioorg Med Chem 2006;14:2602-2612.
6. De Casto WV, Mertens-Talcott S, Rubner A, Butterweck V, Dernedorf H: Variation of flavonoids and furanocoumarines in grapefruit juice: a potential source of variability in grapefruit juice-drug interaction studies. J Agric Food Chem 2006;54:249-255.
7. Paine MF, Widmer WW, Hart HL, Pusek SN: A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 2006;83:1097-1105.
8. Lundahl U, Regårdh GC, Edger B, Johnsson G: The interaction effect of grapefruit juice is maximal after the first glass. Eur J Clin Pharmacol 1998;54:75-81.
9. Fuhr U, Müller-Peltzer H, Lopez-Rojas P, Jünemann M, Harder S, Staib AH: Effects of grapefruit juice and smoking on verapamil concentration in steady state. Eur J Clin Pharmacol 2002;58:45-53.
10. Garg SK, Kumar N, Bhargava VK, Prabhakar SK: Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998;64:286-288.
11. Kumar N, Garg SK, Prabhakar S: Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in healthy male volunteers and epileptic patients. Methods Find Exp Clin Pharmacol 1999;21:629-632.
12. Becquemont L, Verstuyft C, Kerb R, et al.: Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther 2001;70:311-316.
13. Fukatsu S, Fukudo M, Masuda S, et al.: Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living donor transplant recipient. Drug Metab Pharmacokinet 2006;21:122-125.
14. Ozdemir M, Aktan Y, Boydag BS, Cingi MI, Musmul A: Interaction between grapefruit juice and diazepam in man. Eur J Drug Metab Pharmacokinet 1998;23:55-59.
15. Lilja JJ, Neuvonen M, Neuvonen PJ: Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol 2004;58:56-60.
16. Kupferschmidt HH, Fattinger KE, Ha HR, Follath F, Krahenbuhl S: Grapefruit juice enhances the bioavailability of HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998;45:355-359.
17. Demarles D, Gillotin G, Bonaventure-Paci S, Vincent I, Fosse S, Taburet AM: Single dose pharmacokinetics of amprenavir co-administered with grapefruit juice. Antimicrob Agents Chemother 2002;46:1589-1590.
18. Penzak SR, Acosta EP, Turner M, et al.: Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics. J Clin Pharmacol 2002;42:1165-1170.
19. Dresser GK, Kim RB, Bailey DG: Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of anion transporting polypeptides. Clin Pharmacol Ther 2005;77:170-177.
20. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ: Effect of grapefruit juice dose on grapefruit-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol 2000;56:411-415.
21. Varis T, Kivisto KT, Neuvonen PJ: Grapefruit juice increases the plasma concentrations of oral methylprednisolone. Eur J Clin Pharmacol 2000;56:489-493.
22. Wen YH, Sahi J, Urda E, Kulkarni S, et al.: Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab Dispos 2002;30:977-984.
23. Hukkanen J, Jacob P 3rd, Benowitz NL: Effect of grapefruit juice on cytochrome P 450 2A6 and nicotine clearance. Clin Pharmacol Ther 2006;80:522-530.
24. Wanwimolruk S, Marquez PV: Variation in content of active ingredients causing drug interactions in grapefruit juice products sold in California. Drug Metab Drug Interact 2006;21:233-243.